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Using Attentional Bias Modification as a Cognitive
Vaccine Against Depression
Michael Browning, Emily A. Holmes, Matthew Charles, Philip J. Cowen, and Catherine J. Harmer
Background: Negative attentional biases are thought to increase the risk of recurrence in depression, suggesting that reduction of such
biases may be a plausible strategy in the secondary prevention of the illness. However, no previous study has tested whether reducing
negative attentional bias causally affects risk factors for depressive recurrence. The current experimental medicine study reports the effects
of a computerized attentional bias modification (ABM) procedure on intermediate measures of the risk of depressive recurrence (residual
depressive symptoms and the cortisol awakening response) in patients with recurrent depression.
Methods: Sixty-onepatientswith at least twoprevious episodesof depressionwhowere currently in remissionwere randomized to receive
either an active (positive) or placebo computer-based ABM regime. The ABM regime presented either pictures of faces or words. Residual
depressive symptoms, measured using the Beck Depression Inventory and the cortisol awakening response were measured immediately
before and after completion of the bias modification and then again after 4 weeks’ follow-up.
Results: Positive, face-basedABM reducedbothmeasures of recurrence risk (BeckDepression Inventory and cortisol awakening response).
This effect occurred during themonth following completion of bias modification. Word-basedmodification did not influence the outcome
measures.
Conclusions: Positive face-basedABMwas able to reduce intermediatemeasures of recurrence risk inpreviously depressedpatients. These
results suggest that ABMmayprovide a “cognitive vaccine” against depression andoffer a useful strategy in the secondary preventionof the
illness.
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D epression is overwhelmingly a recurrent disorder with 80%of patients experiencing more than one episode in theirlifetime (1). Secondary preventative strategies that aim to
lower the risk of recurrence in previously depressed patients are
therefore likely to be a particularly important method of reducing
illness burden.
The highly recurrent nature of depression indicates that certain
individuals possess vulnerability factors that predispose them to
repeatedly develop acute episodes of the disorder. Preventative
treatment strategies are predicated on identifying and ameliorat-
ing these vulnerability factors (2) because doing so will reduce an
individual’s risk of subsequent acute episodes. Previously identified
candidate vulnerability factors for recurrence in depression include
clinical characteristics such as the persistence of subsyndromal
symptoms following treatment (3), social factors (4,5), and mea-
sures of endocrine and neurocognitive functioning such as an ex-
aggerated cortisol awakening response (CAR) (6) and the presence
of negative cognitive biases (7). The current study focuses on neg-
ative cognitive biases and examines whether they may be a useful
target in the secondary prevention of depression.
Depressed patients tend to pay attention to, interpret, and re-
member information in a negative manner (7). Importantly, how-
ever, thesenegative cognitivebiases are foundnot only in currently
depressed patients but are also present in nondepressed individu-
alswhoare at high risk of developingdepression. This indicates that
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http://dx.doi.org/10.1016/j.biopsych.2012.04.014 © 201egative cognitive biases may be true vulnerability factors for de-
ression rather than simple markers of mood. For example, de-
ressed patients tend to have difficulty redirecting their attention
8) away from negative, relative to positive, stimuli (9,10) with a
imilar pattern being found in previously depressed, currently eu-
hymic individuals (11) and in never-depressed individuals who are
t high risk because of a family history of the illness (12). Thus, there
s evidence that negative attentional biases are associated not just
ith current depressive symptoms but also with the risk of devel-
ping depression. However, for a risk factor to be considered a
arget for preventative interventions, there should be a direct
ausal relationship, rather than simply an association, between it
nd the likelihood of recurrence. Recent experimental work has
emonstrated that attentional biases may be trained using com-
uterized attentional bias modification (ABM) tasks (13–15). These
eceptively simple tasks (Figure1C) alter attentional biasbyplacing
probe, to which the patient has to respond, behind either a posi-
iveor negative stimulus. If theprobealways appears in the location
f the positive stimulus, a habit of automatically directing attention
oward positive stimuli is encouraged—that is, patients develop a
ositive attentional bias. This manipulation may be compared to a
eutral control condition in which the probe appears equally often
ehind the positive and negative stimuli and that therefore does
ot alter attentional bias. In this study, we used a randomized
xperimental design to testwhether ABMcausally influencesmark-
rs of relapse risk in depression. In other words, we assess whether
BMmaybe used as a “cognitive vaccine” (16) in individuals at high
isk of recurrence.
We used an experimental medicine approach to test whether
odification of negative attentional bias in previously depressed
atients was able to influence known risk factors for depressive
ecurrence. Currently euthymic, previously depressed patients
ere randomly assigned to receive either an active (positive) or
lacebo (neutral) ABM regime, whichwas completed over 2 weeks.
he impact of the bias modification regime on two measures of
ulnerability to depressive recurrence, residual depressive symp-
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M. Browning et al. BIOL PSYCHIATRY 2012;72:572–579 573toms (3) and CAR (6), was assessed before and after completion of
the regime and then again after 1 month follow-up. The study also
examined the most effective method for delivering the bias modi-
fication. Previous work using ABM in other populations has em-
ployed either word or face stimuli in the tasks (13). Although verbal
stimuli maymore closelymatch the abstract ruminative processing
style characteristic of depression (17), visual face stimuli are
thought to elicit a more profound emotional response (18) and
therefore may result in a greater bias modification effect. Patients
were therefore additionally randomized to receive bias modifica-
tion with either a word- or face-based task (Figure 1B).
We predicted that positive, relative to placebo, ABMwould lead
to a reduction in themarkers of recurrence risk (residual depressive
symptoms andCAR). Positive attentional bias is not thought to alter
mood directly but rather to protect against the negative effects of
stressful environmental interactions (7); it was therefore predicted
that theeffect ofABMonmoodwouldaccumulatewithexposure to
such interactions over time—that is, residual depressive symptoms
andCARwoulddecreaseacross thebiasmodificationand follow-up
period. Because no previous study has compared word- and face-
based ABM in this population, we had no strong rationale for pre-
dicting whether one form would be more effective than the other.
Methods andMaterials
Patients
Sixty-one patients with recurrent depression who were not cur-
Figure 1. Study design and attentional biasmodification (ABM) task used. (A
eeks of ABMand then again amonth later. The assessmentmeasures comp
o one of four treatment groups using a factorial design. This design allows
ell any interaction between the two. (C) Two example trials from the ABM t
probe (oneor twodots) towhich thepatients had to respond.Duringpositi
he placebo ABM condition was identical in every respect other than that
uring ABM were either faces (shown) or words.rently depressed were recruited from the community by advertise- pent. The inclusion criteria were two or more episodes of lifetime
epression with no episodes occurring within the previous 6
onths. Diagnosis of lifetime depression (as well as any comorbid
iagnoses) and absence of current depression was confirmed dur-
ng a screening visit in which the Structured Clinical Interview for
SM-IV Clinical Version (SCID-CV) (19) was administered by a
rained interviewer. Exclusion criteriawere age less than 18 ormore
han 65 years, use of any psychotropicmedication or psychological
herapy within the previous 3 months, and a current or lifetime
sychotic disorder or current symptomatology (e.g., suicidality)
hat was deemed to require immediate treatment. Basic demo-
raphic and clinical information, including an estimate of verbal IQ
National Adult Reading Scale; NART) (20) was collected at the
creening session and is summarized in Table 1. Written informed
onsent was obtained from all patients before enrollment into the
tudy, which had received approval from the local research ethics
ommittee. Full data were available on all but one participant who
id not attend the final assessment session. Data analysis was car-
ied out on all available data (i.e., 61 patients for the first two assess-
ent sessions and 60 patients for the final session).
rocedure
The study procedure is summarized in Figure 1A. Following
nrollment in the study, patients were randomized (with stratifica-
ionbygender) into oneof four groups (Figure 1B). Groupmember-
hip (positive face ABM, placebo face ABM, positive word ABM,
ients completed three assessment sessions, immediately before and after 2
duringboth sessions are listed. (B) Eachparticipantwas randomly assigned
sment of the main effects of both ABM type and the stimuli used in ABM as
mpleted by patients. On each trial two stimuli were presented, followed by
M (shown) theprobe appearedbehind themorepositive of the two stimuli;
robe was equally likely to appear behind either stimulus. The stimuli used) Pat
leted
asses
ask co
veAB
the placeboword ABM) determined the form of ABM undertaken. ABM
www.sobp.org/journal
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wwas completed twice daily over the course of 14 days (28 sessions
total). Patients were informed that the study examined how “think-
ing style changed over time and how this is related to mood”; the
specific rationale underlying the ABM was not explained, and pa-
tients were blind to group allocation. Data were collected in three
assessment sessions, the first immediately before ABM com-
menced, the second immediately after the 2weeks of ABM, and the
last 1 month following this. On the morning of each assessment
session, patients collected waking salivary samples for analysis of
cortisol, and during the assessment sessions, self-report symptom
measures and tasks assessing attentional bias were collected. The
bias assessment tasks provide a check that the ABM regime was
having the expected impact on attentional function.
ABM Task
TheABMtaskused (Figure 1C)was a computerized, visual-probe
biasmodification procedure (21) that was developed to alter atten-
tional bias to emotional information. Similar tasks have been found
to improve symptomsof current anxiety anddepression (13,22). On
the basis of the widely used visual-probe task (23), a pair of stimuli
were briefly presented and followed by a probe (one or two dots),
which appeared behind one of the stimuli. Participants were re-
quired topress oneof twobuttons to indicate thenumber of dots in
the probe. The type of stimuli used during the ABM taskwere either
pictures of faces or words and were selected to have positive, neu-
tral, or negative valencewith each trial of the task displaying stimuli
from two valences (vertical visual angle between the center of
stimuli 12°). This resulted in three possible stimuli pair types:
positive-neutral, positive-negative, and negative-neutral. During
the positive ABM condition, the probes replaced the relatively pos-
itive stimuli of a given pair and thus, when completing the positive
ABM, patients learn to deploy their attention toward positive
stimuli as they predict the probe location—that is, they develop
a positive attentional bias. Placebo ABM was identical in every
respect other than the location of the probe, which was equally
often found behind the positive and negative stimuli. Further
details concerning the ABM task and stimuli selection are pro-
vided in Supplement 1.
Measures of Residual Symptoms
Residual symptoms were measured at all three assessment ses-
sions using standardizedquestionnaires of self reporteddepressive
Table 1. Participant Demographic and Clinical Information
Pos
Faces (n 16)
Age, Mean (SD), Years 34.6 (12.2)
Sex, n, F:M 10:6
Years of Education, Mean (SD) 16.8 (3.8)
VIQ (NART), Mean (SD) 114.6 (7.1)
o. of Previous Episodes, Mean (SD) 3.6 (1.9)
otal Illness Duration, Mean (SD), Months 22.3 (12.7)
Time Since Last Illness Episode, Mean (SD), Months 22.3 (21.3)
BDI Score, Mean (SD) 5.9 (6.9)
rait-STAI, Mean (SD) 45.3 (6.6)
HRSD, Mean (SD) 3.1 (4.1)
Compliance with ABM, n, Compliant:Noncompliant 14:2
ABM, attentional biasmodification; BDI, Beck Depression Inventory; F, fe
Reading Scale; Trait-STAI, the trait subscale of the Spielberger State-Trait An
aThe p value reported is the lowest of the three comparisons: main effec
bStatistical analysis performed using logistic regression model; a univari(Beck Depression Inventory; BDI) (24) and anxious (Trait subscale of w
ww.sobp.org/journalhe Spielberger State-Trait Anxiety Inventory) (25) symptoms.
hesemeasureswere supplemented by an observer reportedmea-
ureof depressive symptoms, theHamiltonRatingScale forDepres-
ion (HRSD) (26), which was collected by a trained administrator
ho was blind to participant group allocation.
easures of Waking Cortisol
Patients collected their own saliva samples upon waking on the
orning of each assessment session. The patients were carefully
nstructed to take the first saliva sample as soon as they awoke and
o take four additional samples at 15-minute intervals. During the
ampling, the subjects were asked not to eat or drink. Saliva sam-
les were collected by using a salivette device (Sarstedt, Leicester,
nited Kingdom) in which saliva is absorbed into a cotton roll and
hen expressed into a sterile vial. The CARwas defined as the differ-
nce between the cortisol level on waking and the highest level
chieved in the following 4 samples (27). See Supplement 1 for
etails of the cortisol assay used.
easure of Attentional Bias
Standardvisual-probe taskswereused toassess attentional bias.
hese tasks were identical to the ABM task with the exception that
he location of the probe was random for all patients (allowing
ssessment of attentional bias). Regardless of the type of stimuli
sed in the ABM task, all patients completed separate word- and
ace-based visual-probe tasks during each assessment visit. A mea-
ure of attentional bias toward the relativelymore positive stimulus
as calculatedby subtracting the average reaction time to respond
o trials in which the probe replaced the positive stimulus from
hose in which the probe replaced the relatively negative stimulus.
tatistical Analysis and Data Reduction
Analysis was performed using split plot analyses of variance
ANOVA)with the between subject factors of ABM type (positive vs.
lacebo) and ABM stimuli (words vs. faces). Time (before ABM, after
BM, follow-up) was included as a within-subject factor. Where
ssumptions of equality of variance were notmet, the Huynh-Feldt
orrection was used, although unadjusted degrees of freedom are
eported for clarity. For the visual probe data, mean reaction times
ere used in the analysis. These were calculated after removing
rror trials and extreme responses, which were defined as those
BM Neutral ABM
paWords (n 16) Faces (n 14) Words (n 15)
40.9 (11.3) 37.8 (11.5) 40.9 (13.5) .14
10:6 10:4 10:5 .59b
16.9 (4.0) 17.4 (3.0) 16.2 (1.7) .43
114.6 (7.2) 117.6 (5.5) 117 (6.3) .17
3.1 (1.1) 3 (1.0) 3 (1.2) .22
31.9 (45.2) 32.8 (34.7) 21.6 (23) .21
41.6 (41.2) 48.6 (80.6) 38.4 (86.8) .36
6.3 (5.4) 4.3 (3.7) 3.8 (4) .14
44.4 (15) 44.1 (12) 43.9 (11.5) .86
2.9 (2.5) 1.8 (2.1) 3.1 (2.9) .33
14:2 13:1 12:3 .5b
HRSD, Hamilton Rating Scale for Depression; M,male; NART, National Adult
Inventory; VIQ, Verbal Intelligence Quotient.
BM stimuli, main effect of ABM type, or the stimuli type interaction.
alysis of variance was performed in all other analyses.itive A
male;
xietyhich lay outside 200–1200msec orwhichwere greater than three
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M. Browning et al. BIOL PSYCHIATRY 2012;72:572–579 575standard deviations from an individual’s mean (extreme outliers
were removed before calculating individual means and standard
deviations because these measures are particularly sensitive to the
effects of outliers; however, the results from the visual probe task
were identical if outliers were left in and median reaction times
were used). Three patients had extreme levels of cortisol excretion
(i.e., 3 SD from the group mean) and were not included in the
analysis.
Results
Group Demographics, Baseline Measures, and Compliance
As can be seen from Table 1, the groups were well matched on
aseline demographics, IQ, and measures of illness severity. Pa-
ients had been depressed on an average of three previous occa-
ions. Compliancewas generally highwith only eight patients com-
leting fewer than 25 sessions of ABM and no difference in
ompliance between the groups.
he Effect of ABM on Residual Symptoms
Positive, relative to placebo, ABM influenced the residual de-
ressive symptoms reported by patients using the BDI, but this
Figure 2. The effects of attentional bias modification (ABM) on residu
C, D) and on symptoms of anxiety measured using the trait-STAI (E, F). Sym
easured at three time points; before biasmodification, after biasmodificat
ere significantly altered by face- but not word-based ABM. The effect of A
odificationperiod. Solid line, positiveABM;dashed line, placeboABM. Error
Inventory; HRSD, Hamilton Rating Scale for Depression; Trait-STAI, the traitffect depended on whether the ABM used faces or words [ABM sype ABM stimuli time; F (2,112) 3.7, p .03]. There was no
eneral ABM type time effect [F (2,112) 1.1, p .35]. As can be
een from Figure 2 positive, face-based ABM lead to a reduction of
ymptoms compared with placebo ABM [Figure 2A; F (2,56)  3.7,
 .03], whereas word based ABMhad no significant effect [Figure
B; F (2,56) 1,p .4]. Interestingly, the beneficial effect of positive
ace ABM displayed a time lag; symptoms did not change across
he2weeks ofABM [F (1,28)1,p .5]; rather, they reducedduring
he follow-up period [F (1,28)  5.9, p  .02] with this change
esulting from a significant drop in symptoms reported by the
ositive face ABM group [t (15)  2.4, p  .03] and no significant
hange seen in the placebo face ABM group [t (13) 1, p .4].
Observer reported depressive symptoms, measured using the
RSD, revealed an identical ABM type ABM stimuli time inter-
ction [Figure 2C and 2D; F (2,112) 3.4, p .04]; however, in this
ase, the post hoc tests of the interaction for face training was
ignificant only at a trend level [F (1,28) 2.9, p .09].
Symptoms of anxiety, measured using the trait subscale of the
TAI displayed the same specific effect of positive face ABM as that
een for the BDI [Figures 2E, F; F (2,112)  3.3, p  .05] with the
eneficial effect again occurring during follow-up [F (1,28)  5.2,
 .03] and being driven by a significant reduction of anxious
mptoms of depression measured using the BDI (A, B) and the HRSD
s, which are displayed as a change from baseline of the mean scores, were
nd after 1-month follow-up. The symptoms of both depression and anxiety
curred during follow-up with no difference in groups seen during the bias
represent SEM. *p .05 forposthoc test of interaction. BDI, BeckDepression
ale of the Spielberger State-Trait Anxiety Inventory.al sy
ptom
ion, a
BM oc
barsymptoms in the positive face ABM group [t (15) 2.4, p .03].
www.sobp.org/journal
a
F
t
p
p
r
.
T
i
a
T
e
b
H
d
A
s
w
p
i
m
A
w durin
E f inte
m
576 BIOL PSYCHIATRY 2012;72:572–579 M. Browning et al.
wThe Effect of ABM on the CAR
Analysis of the CAR response revealed a significant ABM type
ABM stimuli interaction [F (1,53) 4.3, p .04], which was present
cross the three time points [ABM type  ABM stimuli  time;
(2,106)1, p  .4]. In keeping with the effects on residual symp-
oms, face-based ABM influenced the CAR [Figure 3A; F (2,54) 4,
 .02], whereas word-based ABM did not [Figure 3B; F (2,52) 1,
 .8]. Specifically, positive relative to placebo face ABM caused a
eduction of the CAR across the follow-up period [F (1,27) 5, p
03] with no change being seen during ABM [F (1,27)  1, p  .9].
his relative reduction was produced by a nonsignificant decrease
n the positive ABMgroupduring follow-up [t (14) 1.7, p .1] and
nonsignificant increase in the placebo group [t (13) 1.5, p .2].
Figure 3. The effects of attentional biasmodification (ABM) on cortisol awak
measured before bias modification, after bias modification, and after 1-mon
ord-based ABM (B) had no effect. Again, the effect of face ABM was seen
rror bars represent standard error of the mean. *p .05 for post hoc test o
Figure 4. The effects of attentional bias modification (ABM) on attention
calculated so that a greater positive number represents increased vigilance f
negative stimulus. Results display the change frombaseline of themean atte
1-month follow-up. Positive face-based ABM (A) produced a significant incr
(B) resulted in a trend-level decrease in vigilance. Unlike the measures of recu
odification period. Solid line, positive ABM; dashed line, placebo ABM. Error bar
ww.sobp.org/journalhe Effect of ABM on Attentional Function
Positive relative to placebo bias modification produced a differ-
ntial effect on attentional bias (Figure 4), asmeasured by theword
ased visual-probe task [ABM type time; F (2,112) 3.1, p .05].
owever, unlike theprevious results, this effect did not significantly
iffer between the face- and word-trained groups [ABM type 
BM stimuli  time; F (2,112)  1, p  .9]. The effect of ABM was
een across the bias modification period [F (1,57)  8.3, p  .006]
ith no significant change occurring across follow-up [F (1,56) 1,
 .4]. When considering the within group effects produced, pos-
tive-faceABM led toa significant increase inpositivebias across the
odification period [t (15)  3.7, p  .002], whereas face placebo
BM did not change the bias [t (13)  1, p  .9]. Interestingly, the
response (CAR). Results display the change frombaseline of themean CAR
low-up. Face-based ABM (A) produced a significant effect on CAR, whereas
g the follow-up period. Solid line, positive ABM; dashed line, placebo ABM.
raction.
ilance to word stimuli measured using the visual probe task. Vigilance is
positive stimulus, whereas a negative number represents vigilance for the
al biasmeasuredbefore biasmodification, after biasmodification, and after
in vigilance toward the positive stimuli, whereas placebo word-based ABMening
th folal vig
or the
ntion
easerrence risk (Figures 2 and 3), the effect of ABM was seen during the bias
s represent standard error of the mean. *p .05 for post hoc test.
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M. Browning et al. BIOL PSYCHIATRY 2012;72:572–579 577effect of word ABM was driven by a trend level decrease in bias in
the placebo word group [t (14) 2.1, p .051] with no effect seen
or positive word ABM [t (15)1, p  .5]. The correlation between
hange in attentional bias across the bias modification period and
eduction in BDI or CAR across the follow-up period in the positive
ace-ABMgroupwas not significant [r(16) .37, not significant, and
(15) .34, not significant, respectively]. Additional analysis is pro-
ide in Supplement 1.
Attentional bias, assessed using face stimuli, was insensitive to
the effect of the ABM interventions [F (2,112)1, p  1]. This re-
mained the case when analysis was restricted to those who had
completed face based ABM [F (2,56) 1, p .7].
Discussion
In this study, an experimental medicine model was used to test
the prediction that alteration of attentional bias using a simple
computerized bias modification task would causally influence
markers of the risk of depressive recurrence. The results indicate
that positive ABM, when administered using pictures of faces, was
able to reduce twomeasures of risk of depressive recurrence: resid-
ual depressive symptoms as measured by the BDI and the CAR.
Reminiscent of the delay in onset of therapeutic effect reported for
antidepressant medications (28), the benefit of face-based ABM
was found to lag behind its administration. In contrast, whenwords
were used in the ABM task, no significant effect on recurrence risk
was seen. These results support the proposal that modification of
attentional bias, at leastwhen achieved using faces,may be used as
a cognitive vaccine (16) in the secondary prevention of depression.
Cognitive models (7) of depression have suggested that nega-
tive attentional biases are causally related to recurrence risk.
Consistent with this, previous laboratory-based studies have
demonstrated negative attentional biases in populations with a
heightened risk of developing further depressive episodes (11,12).
However, cross-sectional studies such as these leave open the pos-
sibility that negative attentional biases are markers of depressive
risk rather than causally influencing that risk. The finding thatmod-
ifying the biases produces change in other measures of recurrence
risk reported here provides the first experimental evidence sup-
porting a causal role for these negative biases in the risk of recur-
rence. These results are consistent with a growing recent literature
suggesting that modifying biases directly through computerized
tasks canbebeneficial for psychopathology in anxiety (13) andwith
an emerging literature suggesting that such techniques may be
used in depression (29).
Secondary prevention is recognized as a key goal in the long-
term management of depression (28). The current study provides
initial evidence for a novel method of achieving this goal. Specifi-
cally, it predicts that using face-based positive ABMwill reduce the
likelihood of developing further episodes of depression. Ultimately
these results, which used intermediate markers of risk of recur-
rence, must be confirmed in large-scale trials in which patients are
followed up for a sufficient period of time to allow an effect on
clinical recurrence rates to become apparent. However, the experi-
mental medicine approach used in this study provides an efficient
means of initially assessing and refining novel treatments before
committing to large-scale clinical trials (30). The success of the face-
rather than word-based ABM demonstrated in this study is an ex-
ample of the insights this approach can provide. Whereas positive
face-based ABM led to an increase in positive attentional bias as
well as improvement in both residual symptoms and CAR, positive
word-based ABM had none of these effects. The differential impact
of the two forms of ABM may reflect the greater emotional impact ff the biologically prepared faces when compared with the more
bstract verbal stimuli (18). Regardless of the specific reason for the
ifference in efficacy, the value of the current study is in suggesting
hat future trials of ABM in depression would be wise to use face
timuli.
A number of previous studies have linked both residual depres-
ive symptoms and the function of the hypothalamic-pituitary-
drenal axis to recurrence risk in depression. Conceptually the as-
ociation between persistence of symptoms following treatment
nd subsequent recurrence is particularly straightforward and, in-
eed, a number of prospective clinical studies have demonstrated
ignificantly increased recurrence rates in patients with such symp-
oms (e.g., from 25% to 76%) (31,32). Although the measure of
ypothalamic-pituitary-adrenal axis dysfunction used in our study,
he CAR, suggests a possible mechanism through which the risk of
ecurrence may be raised, the clinical evidence linking raised CAR
nd depressive recurrence is somewhat less developed than for
esidual symptoms because it has never been used, to our knowl-
dge, to directly predict recurrence rates in longitudinal studies.
owever, cross-sectional studies provide indirect evidence of such
link by demonstrating that CAR is raised not only in patients who
redepressed (33) but also innondepressedparticipantswhoare at
igh risk of recurrence or illness onset because of a personal (34) or
amily (35) history of the illness.
A related question concerns the precise mechanism through
hich ABM was able to alter depressive symptoms in the current
tudy. Previous authors have suggested that negative attentional
iases may alter depressive symptoms via an effect on ruminative
rocesses (36). Our results raise an additional possibility: that the
ffect of ABM was mediated via the changes in CAR—that is, posi-
ive face-ABM reduced CAR response, which in turn reduced de-
ressive symptoms. However, the sample sizes used in the current
tudy were not sufficient to support the formal mediation analysis,
hich would be required to test this proposal. Furthermore, no
ignificant correlations were found between change in attentional
ias during ABM and change in either BDI or CAR during follow-up
n the positive face ABM group. Thus, although the current study
as able todemonstrate a causal influenceofABMonbothCARand
esidual symptoms, the precisemechanisms underlying these find-
ngs remain obscure.
These results may be relevant to understanding the mecha-
isms of complex psychotherapies. A number of these psychother-
pies, such as cognitive behavioral therapy (37) and mindfulness
herapy (38), havebeenassociatedwith reduced recurrence rates in
epression. It has been suggested that both of these forms of
herapy work, at least in part, by altering attentional function
39,40). The ABM used in the current study may be viewed as a
istillation of one component of these more complex therapies
14,41,42) and suggests that the affective attentional bias compo-
ents of the therapies may account for some of their effect on
ecurrence rates.
Some limitations of the study should be acknowledged. First, to
nsure that patients were not currently depressed, we required a
eriodof at least 6months since the resolutionof the last episodeof
epression. However, it has been estimated that up to 30% of
atientswill relapsewithin 3months of recovery (43), and therefore
ur recruitment strategy may have biased our sample toward pa-
ients with a relatively favorable illness course. Consistent with this,
aseline levels of depressive symptomswere relatively low, and the
ffect of ABM appeared more pronounced when symptoms were
easured using a subjective (BDI) than objective (HRSD) rating.
econd, the ABM task and collection of saliva samples was per-
ormedby thepatientsoutsideof a laboratory setting. It is likely that
www.sobp.org/journal
11
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
578 BIOL PSYCHIATRY 2012;72:572–579 M. Browning et al.
wthis aspect of the experimental design introduced a degree of vari-
ability in the performance of these tasks. However, we believe that
the protocol used in the current study represents a pragmatic bal-
ance between the need for experimental precision and the burden
this would place on patients. Third, the impact of ABM on atten-
tional bias was measured using both face- and word-based visual
probe tasks; however, the predicted effect of ABM was only seen
when bias was measured with words. In a recent study, we found
that a face-based visual probe task was sensitive to the effects of a
similar ABM regime (30), so it seems unlikely that the task itself is
insensitive. It is possible that the use of multiple manipulation
check tasks (i.e., both word and face visual probe tasks) in the
current study lead toparticipant fatigue and reduced the sensitivity
of individual measures. Last, although 61 patients were recruited
into the current study, the factorial design used meant that each
group contained only a quarter of this number; it may therefore be
that subtle effects of ABM, and in particular the effect of a word-
based procedure, would be detectable if the sample size had been
larger.
In this experimental study, positive face-based attentional bias
modification was found to produce similar reductions in two inter-
mediate riskmarkers for depressive recurrence: residual depressive
symptoms and CAR. These results provide the first experimental
evidence that attentional bias modificationmay form the basis of a
useful approach in the secondary prevention of depression.
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